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Acute Burkitt's Leukemia: Case Report and Literature Review
S. Raman, MD,* S. M. Saeed, MD,* and K. R. Kini, MD**

The occurrence of leukemia in Burkitt's lymphoma, with or
without visceral or nodal tumefacdon is uncommon, and
its inidal presentation as leukemia is even more unusual.
Because it has a poor chemotherapeutic response and a
grave prognosis, it is important to recognize this unusual
leukemia correctly. Our report describes the clinical and
pathologic findings of Burkitt's lymphoma cell leukemia in
a five-year-old white boy who presented with abdominal
distension, hepatosplenomegaly, and
lymphadenopathy.
Blood examinadon revealed normocydc
normochromic

anemia, erythroblastosis, slight leukocytosis, and the presence of numerous (24%) blasts. A diagnosis of Burkitt's
lymphoma was established on the basis of morphologic,
cytochemical, and immunologic studies performed on the
blasts. When the chemotherapy protocol for the lymphoma
was administered, the patient responded well initially but
suffered uric acid nephropathy, which was successfully
treated. However, within two weeks he had a rapid relapse
of leukemia and died four months after admission.

Case Report

B

urkitt's lymphoma is a bone tumor of the jaw usually
found in Africa (1,2). Although ft has been known to
involve organs other than the jaw, the incidence of bone
marrow involvement is still not as common as with other
non-Hodgkin's lymphomas (3). In the American variety of
Burkitt's lymphoma, bone marrow involvement has been
reported in 8% to 30% of cases (4-6). In rare instances,
leukemia may occur during the course of the disease,
usually as a terminal event.

A five-year-old white boy was admitted with complaints of
abdominal pain associated wfth increasing abdominal distention and vomiting that had lasted forone week. His past
medical history and family history were unremarkable.
Physical examination revealed a pale child with generalized lymphadenopathy. Chest examination revealed decreased breath sounds and dullness to percussion in both
bases. The heart rate was 150/min with regular rhythm.
Blood pressure was 120/60. His abdomen was distended
with a prominent fluid wave. Spleen was enlarged to 4 cm
below the left costal margin, and the liver was palpable at
the right costal margin.

Very few cases have been reported in which this disease
presented initially as true leukemia (7-12), and fewer have
been studied in detail (8,10). We report such a case of
leukemia with its characteristic clinical, histologic, and
immunological features.

The laboratory findings were hemoglobin 10.5 gm%, hematocrit 32.3%, white cell count 19,600 x ^ 0 \ platelets
286,000/mm3, white cell differential count 44% PMNs, 8%
bands, 4% metamyelocytes, 3% myelocytes, 2% promyelocytes, 5% monocytes, 10% lymphocytes, and 24%
blasts with basophilic cytoplasm containing multiple vacuoles (Fig. 1). The only other abnormal laboratory findings
at this time were an elevated serum lactic dehydrogenase
(LDH) of 2,480 U/L and an increased erythrocyte sedimentation rate of 22 mm/hr.
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The chest radiograph revealed bilateral pleural effusion. A
computerized axial tomogram of the abdomen demonstrated enlarged lymph nodes along the aorta and a mass in
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the area of the terminal ileum. Also seen was right-sided
hydronephrosis, possibly secondary to partial obstruction
at the ureteropelvic junction.

sky" infiltrate composed of undifferentiated blast cells and
phagocytic, benign histiocytes (Figs. 2,3). In the imprints
the blasts had fairly round, noncleaved nuclei surrounded
by a rim of deeply basophilic and vacuolated cytoplasm
(Fig. 4). The nuclear chromatin was fine with two to four
small to medium-sized nucleoli. The cells produced significant pyroninophilia with methyl green pyronin stain and
stained negatively with para-aminosalicylic acid (PAS). An
iliac bone marrow aspirate (Fig. 5) and biopsy indicated
massive infiltration of the marrow by the undifferentiated
blasts. Thoracentesis yielded serosanguinous fluid, with
35% lymphoblasts. Cerebrospinal f l u i d analysis was
nondiagnostic.

A biopsy of the supraclavicular lymph node was performed, and when the specimen was stained ( H & E stain)
and examined, partial effacement of normal lymphoid
architecture was seen due to a monotonous but "starry

Fig. 1: Left
Burkitt's leukemia cell in peripheral blood smear. Leishman stain
(1000X).
Fig. 2: Right
Sectk>n of lymph node involved by the neoplasm showing characteristic
starry sky pattem. H & E stain (63X).

Fig. 5
Bone marrow smear showing extensive infiltration with Burkitt's tumor
cells. Leishman stain (1000X).

On the basis of the above findings, acute Burkitt's lymphoma cell leukemia was diagnosed. A modified LSA2L2
protocol for pediatric lymphomas was prescribed for the
patient, and chemotherapy was initiated with Cytoxan
(1200 mgm/M2 IV on day 1), vincristine (1.5 mgm/M2 IV
weekly times four doses), prednisone (60 mgm/M2 in four
divided doses for 28 days), methotrexate (6.25 mgm/M2 IT
weekly times four doses), and daunomyecin (60 mgm/M2
IV on two successive days between the second and third
vincristine injections). He also received allopurinol. However, when the boy's blood urea nitrogen (90 mg/dl) and
uric acid (21 mg/dl) became markedly elevated, it was
apparent that he was developing uric acid nephropathy and
renal failure due to the rapid breakdown of his tumor. He
was also hypertensive and developed alpha streptococcal
septicemia. The uric acid nephropathy was successfully
treated with intravenous fluids, allopurinol, diamox, and
alkalinization of urine. His hypertension was controlled
w e l l w i t h thiazide and a p r i z o l i n e . T i c a r c i l l i n and tobramycin were instituted to treat the sepsis. He was discharged on maintenance doses of prednisone.

Fig. 3: Left
Higher magnificatbn of lymph node section showing monomorphic
populatbn of undifferentiated blasts interspersed with benign phagocytic histiocytes. H & E stain (400X).
Fig. 4: Right
Imprints from lymph node showing Burkitt's tumor cells. Leishman stain
(1000X).
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TABLE I
Clinical and Laboratory Features of
Cases Diagnosed as Acute Burkitt's Cell Leukemia

Case

Age Sex
17

2(8)

319,

14

6(12)

121/2

Liver
+

M

Swelling
cheeks,
proptosis,
bleeding from
gums, in
stools

-n-

M

Neck
swelling,
pain in
jaw witti
loosening of
teeth,
bleeding gums

-H-

Other

90%
blasts

—

Hb
G/dl
10

WBC
27000/mm3
Blasts, 65%

not
done

WBC
59,700/dl
Numerous
blasts

not
done

Tumor,
left
upper lid

Sheets of
blasts

7.2

WBC
5800/mm3
scanty
blasts

not
done

BUN

Not
done

Suggestive of
non-B
non-T
possibly null

SCOT,
LDH,
BUN,
Uric acid

Elevated

not
done

Uric acid. Not
total
done
protein

10.2 WBC
14,200/mm3
Blasts, 22%

M

Anorexia,
anemia,
abdominal
swelling
and pain

-F-l-

Abdominal 100%
masses
blasts

9-5 WBC
25,299/ul
Blasts, 9%

F

Acute
abdominal
pain

M

Vomiting,
abdominal
pain

++

Unremarl<able

4,5

Petechiae, 88%
enlarged
blasts
ovary
Involved
by lymphoma

-F-F

LDH,
SCOT
BUN,
Uric acid

E.B.
Virus
Studies

100%
blasts

+

Fever,
facial
swelling,
bleeding gums

Abnormal
Biochemical
Findings

Facial
swelling

Fever,
abdominal
pain

15

8
our

Lymph
Nodes Spleen

Hematuria,
Nuchal ache,
Weight loss,
Abdominal,
chest pain

14

5(11)

Presenting
Features

Bone
Marrow
Morphology

WBC Count
with %
Blasts in
Cell
Peripheral
Marker
Blood
Studies

Not
elevated

Lymphomatous
tumor In
ileum,
mesentery

Massive
infiltration with
blast
cells

12.5 WBC
16,700/mm3
Blasts, 30%

IgM
kappa
in 60%
of
blasts

Uric acid.
SCOT,
alkaline
phosphatase

Normal

Breast
masses,
maxillary
swelling,
proptosis

Massive
Infiltration with
blast
cells

12

WBC
33,000/mm3
Blasts, 80%

IgM
kappa
in 90%
of
blasts

LDH

Normal

Mass in
terminal
ileum,
ureter;
pleural
effusion

100%
blasts

10.5 WBC
19,600 X I 0 ^
Blasts, 24%
to 50%

IgM
kappa,
igD

LDH

Normal

When the patient was discharged, his serum LDH was 11
U/L. Both uric acid and blood urea nitrogen were normal,
and no blasts were seen in the peripheral blood smear. His
abdominal girth was significantly reduced; a CAT scan of
the abdomen demonstrated a marked reduction in the size

of periaortic and ileocecal masses. A repeat bone marrow
aspirate showed slight hypoplasia but no tumor. However,
within two weeks of the patient's discharge, the peripheral
blood examination revealed 50% blasts. Immunological
marker studies indicated that monoclonal membrane-
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TABLE II
Response to Therapy and Prognosis In Cases
Diagnosed as Acute Burkitt's Cell Leukemia

Case

Chemotherapy

Initial
Response
to Therapy

Mode
of
Relapse

Duration
of Remission

1'^'

Vincristine,
prednisone

Dramatic and
complete

2""

Vincristine,
cyclophosphamide
prednisone

Poor, died four
days after
admission

3'"

Cyclophosphamide

Complete
remission

20 days

Cyclophosphamide

Complete
remission

6 months

5'"'

Vincristine,
methotrexate,
prednisolone

Complete
remission

3 weeks

6"^'

Cyclophosphamide,
vincristine,
prednisone,
methotrexate
(intrathecal)

Complete
remission

3 weeks

Blood and marrow
Meningeal

7"^'

Cyclophosphamide,
vincristine,
prednisone,
methotrexate

Complete
remission

4 weeks

Meningeal
leukemia

8
our
case

Cytoxan,
vincristine,
prednisone,
methotrexate
(intrathecal)

Complete
remission

1 month

Blood and marrow

About 1 week

Length
of Survival

Terminal
Autopsy Findings

3 months

Massive hemorrhage, sepsis,
generalized leukemic
infiltrate

4 days

Neoplastic involvement of
jaws, orbits, marrow,
liver, spleen, Gl tract,
lymph nodes

Blood and marrow

4 months

Extensive marrow involvement with hepatosplenomegaly, lymphadenopathy

Blood and marrow

7V2 months

Sepsis, internal hemorrhage, renal failure;
extensive neoplastic
infiltrate in marrow and
abdominal viscera

3 weeks

Leukopenia, bronchopneumonia

6 months

Marrow and meningeal
involvement, neutropenia
and E. coli sepsis

Blood and marrow
CNS
(positive CSF)

bound IgM (kappa) immunoglobulin was present on 88%
and IgD was present on 65% ofthe blasts. The patient was
hospitalized again for chemotherapy, but he developed
pneumonia as well as persistent thrombocytopenia that
required several platelet transfusions. In spite of vigorous
chemotherapy and supportive measures, his condition became worse, and he died four months after his disease had
been first diagnosed. An autopsy was not performed.

IImonths

4 months

Diffuse neoplastic
involvement of CNS

Massive marrow involvement by neoplasm, pneumonia, severe thrombocytopenia

a terminal phase is not common (4,5,13). Leukemia is not
commonly the initial presenting event, and most such
reports have originated outside the United States. Since
Stevens, et al reported a case of Burkitt's cell leukemia in
1972 (7), only a few addftional cases with the initial
leukemic component have been reported (7-12). It is well
recognized that almost 3% of the acute lymphoblastic
leukemia cells have B-cell immunologic markers and possess cytoplasmic pyroninophilia and vacuolization. These
patients do not have visceral and/or soft tissue involvement
like that seen in Burkitt's lymphoma. Therefore, B-cell
acute lymphocytic leukemia cases (14) should be separated
from cases which have typical clinical and pathologic
findings of Burkitt's lymphoma with a presenting leukemic
component.

Discussion
Burkitt's lymphoma is a well-defined neoplasm (1,2) and
both African (2) and American (3,5) varieties have been
studied. In the American subtype, extensive bone marrow
involvement is more common (4-6), although leukemia as
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The reported cases of Burkitt's leukemia (Tables I and 11) are
similar to the non-African and American Burkitt's lymphomas in their characteristic clinical presentation and multiple organ involvements. Abdominal organ involvement
was most frequent. But unlike the lymphomas, seven of
eight cases of leukemia presented with varying degrees of
generalized lymphadenopathy. Bone marrow involvement
in all cases was always massive, and the peripheral white
cell count in most instances was significantly elevated.
Chemotherapy produced a dramatic initial response in all
cases except for one patient who lived only four days after
admission. However, the remission in all cases was shortlived wfth relapse of leukemia and rapid death. The patients survived after relapse usually less than six months.
Terminal or autopsy findings in seven of eight patients
included widespread neoplastic organ infiltrates with associated sepsis and hemorrhage in some cases. The response
and short survival ofthese patients is similar to that of most
cases of American Burkitt's lymphoma where bone marrow
was extensively involved. Epstein-Barr viral titers were
usually normal or not significantly elevated in all but one
patient (Tables I and 11). This finding supports the contention of some authors (15) that the Epstein-Barr virus titers
may be less significant in non-African Burkitt's leukemia
and lymphoma than in the African variety.

Cadman, et al (17) studied uric acid nephropathy that
developed during effective chemotherapy in Burkitt's lymphoma and leukemia due to rapid cell lysis. As they
indicated, a markedly elevated LDH forewarned us of this
possibility, as did the clinically and morphologically extensive neoplastic infiltrates in our patient. We were thus able
to successfully treat this aspect of the disease.

Conclusion
Cases of acute Burkitt's leukemia differ from the typical
cases of B-cell acute lymphocytic leukemia (B-ALL) with
massive multi-organ involvement. The associated clinical
and pathologic findings of Burkitt's lymphoma do not
occur in cases of B-ALL, although extensive marrow involvement, many blasts in the blood, and lymphadenopathy are common accompaniments. Burkitt's leukemia may
represent a particularly aggressive form of B-lymphoblast
malignancy which shows sudden, massive tumefaction and
leukemia that is difficult to control wfth the commonly
employed chemotherapy for Burkitt's lymphoma or childhood ALL. The few cases in which detailed immunological
studies on the tumor cells have been performed demonstrated monoclonal B-cell markers.

Immunological studies have been performed in only a few
cases of Burkitt's leukemia. In most cases, including ours,
monoclonal surface immunoglobulins (usually IgM kappa)
were consistently present. Presence of delta chains in our
case is not surprising since these are produced by IgMbearing normal or neoplastic lymphoid cells (14,16).

Acknowledgment
We are indebted to Dr. Hajime Hayashi of the Division of
Immunopathology for elucidation of the immunological
markers.

41

Raman, Saeed, and Kini

References
1. Berard C, O'Conor GT, Thomas LB, Torloni H. Memoranda histopathological definitions of Burkitt's tumor. Bull W H O 1979;40:601-07.

10. Heideman RL, Falletta JM, Steuber CP, Starling KA, Rosenberg HS,
Fernbach DJ. Acute leukemia in Burkitt's lymphoma. Med Pediatr
Oncol 1976;2:215-22.

2. Wright D H . Burkitt's lymphoma — A review of the pathology, immunology, and possible etiologic factors. Pathol Ann 1971;6:337-62.

11. Acar S, Tekinalp G, Oxsoylu S, Cevik N, Yasar H. Burkitt's lymphoma
cell leukemia. Acta Haematol (Basel) 1977;57:188-92.

3. Arseneau JC, Canellos CP, Banks PM, Berard CW, Gralnick HR, DeVita
VT. American Burkitt's lymphoma — A clinicopathologic study of 30
cases. 1. Clinical factors relating to prolonged survival. Am J Med
1975;58:314-21.

12. Prococimer M, Matzner Y, Ben-Bassat H, Polliack A. Burkitt's lymphoma cell leukemia — Report of 2 cases in Israel. Cancer 1980;45:
2884-89.

4. Wright D H , Pike PA. Bone marrow involvement in Burkitt's tumor. Br J
Hematol 1968;15:409-16.

13. Bluming AZ, Ziegler JL, Carbone PP. Bone marrow involvement in
Burkitt's lymphoma: Results of a prospective study. Br J Haematol
1972;22:369-76.

5. Brunning RD, McKenna RW, Bloomfield CD, Cocia P, Gajl-Peczelska
KJ. Bone marrow involvement in Burkitt's lymphoma. Cancer 1977;
40:1771-79.

14. Flandrin G, Browet JC, Daniel MT, Prudhomme JL. Acute leukemia
with Burkitt's tumor cells: A study of six cases with special reference
to lymphocyte surface markers. Blood 1975;45:183-88.

6. Banks PM, Arseneau JC, Gralnick HR, Canellos GP, DeVita VT, Berard
CV. American Burkitt's l y m p h o m a — A clinicopathologic study of 30
cases. 11. Pathologic correlations. Am J Med 1975;58:322-29.

15. Levine PH, O'Conor GT, Berard CW. Antibodies to Epstein-Barr virus
in American patients with Burkitt's lymphoma. Cancer 1972;30:610.

7. Stevens DA, O'Conor GT, Levine PT, Rosen RB. Acule leukemia with
"Burkitt's lymphoma cells" and Burkitt lymphoma. Ann Intern Med
1972;76:967-73.

16. Fu SM, Winchester RJ, Kunkel HG. Occurrence of surface IgM, IgD
and free light chains on human lymphocytes. J Exp Med 1974;139:
451-57.

8. Jaiyesimi F, Oluboyedo D, Taylor D, Familuasi JB. Burkitt's lymphoma
presenting as acute leukemia. Acta Haematol (Basel) 1975;54:115-19.

17. Cadman EC, Lundberg WB, Bertino JR. Hyperphosphatemia and
hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's
lymphoma and Burkitt cell leukemia. Am J Med 1977;62:283-90.

9. Cehreli C, Tosun N. Burkitt's lymphoma eel leukemia in a Turkish boy.
Cancer 1975;35:1444-49.

42

